CCKBR-specific antibody

Este producto es parte de CCK - Cholecystokinin A Receptor
CCKBR-specific antibody
Contáctenos para saber el precio

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

Name
CCKBR-specific antibody
Category
Primary Antibodies
Provider
FineTest
Reference
FNab01378
Tested Applications
ELISA, WB, IF

Documentos del producto

Instrucciones
Descargar
Data sheet
Descargar

Especificaciones del producto

Category
Primary Antibodies
Immunogen Target
cholecystokinin B receptor (CCKBR)
Host
Rabbit
Reactivity
Human
Recommended Dilution
WB: 1:500-1:2000; IF: 1:10-1:100
Clonality
polyclonal
Conjugation
Unconjugated
Isotype
IgG
Observed MW
64 kDa
Purity
≥95% as determined by SDS-PAGE
Purification
Immunogen affinity purified
Size 1
100µg
Form
liquid
Tested Applications
ELISA, WB, IF
Storage
PBS with 0.02% sodium azide and 50% glycerol pH 7.3, -20℃ for 12 months(Avoid repeated freeze / thaw cycles.)
UniProt ID
P32239
Gene ID
887
Alias
CCKBR,CCK2 receptor,CK-B receptor,cholecystokinin-2 receptor ,CHOLREC,gastrin/cholecystokinin type B receptor,CCK-B/gastrin receptor,CCK-2R,CCK-B,CCK2R,GASR
Background
Antibody anti-CCKBR
Status
RUO
Note
Mol. Weight 64 kDa

Background

CCKBR, also known as CCK2R, is a G protein-coupled receptor (GPCR) that binds both gastrin and cholecystokinin (CCK) peptides, playing critical roles in gastrointestinal function and brain signaling. It is expressed in the stomach, pancreas, brain, and certain tumors. In the gastrointestinal system, CCKBR regulates gastric acid secretion by stimulating parietal cells and promotes gastric mucosal growth, supporting digestive processes. In the central nervous system, CCKBR is involved in modulating anxiety, pain, and satiety through interactions with neurotransmitter systems. Its activation triggers pathways like phospholipase C (PLC), calcium mobilization, and MAPK signaling, leading to cellular proliferation, enzyme secretion, and neuronal modulation. CCKBR is highly implicated in gastric and pancreatic cancers, where gastrin-mediated activation enhances cell proliferation, survival, and tumor progression. Overexpression of CCKBR has been observed in gastric adenocarcinomas, making it a potential therapeutic target. Additionally, dysregulation of CCKBR signaling contributes to gastrointestinal disorders, including peptic ulcers and Zollinger-Ellison syndrome, characterized by excessive gastrin production. CCKBR is also being explored in neuropsychiatric research for its roles in anxiety and pain modulation. Overall, CCKBR regulates digestive and neuronal processes but contributes to disease progression when overexpressed or dysregulated.

Productos relacionados

abx007382

Gastrin/Cholecystokinin Type B Receptor (CCKBR) Antibody

CCKBR Antibody is a Rabbit Polyclonal Antibody against CCKBR.…

Ver producto
abx015225

Gastrin/Cholecystokinin Type B Receptor (CCKBR) Antibody

Rabbit polyclonal antibody against CCKBR protein. Immunogen region is N-terminal.…

Ver producto
abx111603

Gastrin/Cholecystokinin Type B Receptor (CCKBR) Antibody

Cholecystokinin B Receptor Antibody is a Rabbit Polyclonal antibody against Cholecystokinin B Receptor.…

Ver producto